NCT06643897View on ClinicalTrials.gov

Identification of Barriers and Facilitators of Implementation of the Out-of-Hospital Administration of the Long- Acting Combination Cabotegravir+Rilpivirina.

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

July 16, 2024

Primary Completion Date

October 23, 2024

Study Completion Date

October 23, 2024

Conditions
HIV-1-infection
Interventions
OTHER

Qualitative Interview

40-50 minute-qualitative interview.

Trial Locations (9)

29601

Cs Leganitos, Málaga

29603

Hospital Costa Del Sol, Málaga

29692

Cs San Luis de Sabinillas, Málaga

Cs San Pedro de Alcántara, Málaga

08916

Germans Trias I Pujol Hospital, Badalona

08001

CAP Dr Robert, Barcelona

Centre de Salut Internacional i Malalties Transmissibles Drassanes - Vall d'Hebron, Barcelona

08015

BCN CheckPoint, Barcelona

08035

Hospital Vall D' Hebrón, Barcelona

All Listed Sponsors
lead

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

OTHER

NCT06643897 - Identification of Barriers and Facilitators of Implementation of the Out-of-Hospital Administration of the Long- Acting Combination Cabotegravir+Rilpivirina. | Biotech Hunter | Biotech Hunter